Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- GSK to Directly Compare Pazopanib with Sunitinib in RCC
January 5, 2009
- AZ, BMS to Jointly Commercialize Dapagliflozin in Japan
December 22, 2008
- 7 Organizations Call For Further Discussions on Online Sales of Drugs
December 22, 2008
- Sales of Cytotoxic Chemotherapeutics to Peak at US$16.5 Bil. in 2013
December 22, 2008
- Regulatory Reform Council to Not Include Online Sales of Drugs in Its Recommendation
December 22, 2008
- BUSINESS NEWS IN BRIEF
December 22, 2008
- Crestor Reduces CV Risk in Patients with High High-Sensitive CRP Levels: JUPITER Study
December 22, 2008
- New Fees Related to Generics Claimed by Only a Few Pharmacies
December 22, 2008
- Control of Postprandial Hyperglycemia Important to Prevent CV Events: Prof. Tajima
December 22, 2008
- Most Women Have Not Been Examined for Breast Cancer Despite Willingness
December 22, 2008
- High % of ED Patients with Underlying Conditions Satisfied with Levitra: Bayer Schering
December 22, 2008
- Nichi-Iko Merges 3 Subsidiaries
December 22, 2008
- GLP-1 Analogues, DPP-4 Inhibitors to Cut Treatment Cost for Diabetes: Dr Kobayashi
December 22, 2008
- Daiichi Sankyo Applies for Olmesartan + Ca Blocker Combination
December 22, 2008
- Relenza Should Be More Effectively Used in Combination with Tamiflu: Prof. Matsumoto
December 22, 2008
- DB of Medical Bills to Help Drug Risk Assessment
December 22, 2008
- Prescription of Tamiflu by Phone to Be Permitted upon Onset of Pandemic of New-Type Flu
December 22, 2008
- Aspirin Should Be Reimbursed at Low Doses to Prevent Arteriosclerotic Diseases
December 22, 2008
- Janssen Offers Opportunities to Experience Virtual AD/HD
December 22, 2008
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 22, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…